SalioGen Therapeutics
- Website
- saliogen.com
- Total Funding
- $135.0M
- Last Round
- $115.0M Series BJan 2022
- Rounds
- 2
About
SalioGen Therapeutics is a Biotech company. It has raised $135.0M in total across 2 rounds, most recently a $115.0M Series B round in Jan 2022. Investors include GordonMD Global Investments, EPIQ Capital Group and PBM Capital.
Funding History
Jan 2022
Sign up to see all 2 rounds
Series A through Series B — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/saliogen-therapeutics"><img src="https://indexed.vc/api/badge/company/saliogen-therapeutics" alt="SalioGen Therapeutics on Indexed.vc" width="260" height="76" /></a>